Your session is about to expire
← Back to Search
Pre-operative Antibiotics for Wound Infection
Study Summary
This trial will test whether antibiotics improve outcomes for kids who've had percutaneous surgery for supracondylar humerus fractures. Eligible patients who consent will be followed for 3-6 weeks to see if they experience less pain, quicker healing, and fewer complications.
- Postoperative Wound Infection
- Supracondylar Humerus Fractures
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Are applications to join this clinical experiment being accepted at the moment?
"Based on the information available via clinicaltrials.gov, this medical trial is recruiting participants right now. It was initially listed in August 2017 and its details were most recently updated at the start of December 2021."
What is the aggregate size of participants in this experiment?
"Affirmative. Clinicaltrials.gov displays that this trial is actively recruiting patients, having initially been posted on August 18th 2017 and last edited December 1st 2021. The medical study aims to enroll 200 participants at a single location."
What prior reports have there been regarding Pre-operative Antibiotics?
"Currently, there are 30 active trials for Pre-operative Antibiotics with 8 of these studies in the advanced Phase 3 stage. The majority of test sites are located around Chicago, though a total of 171 facilities across the United States are participating in research involving prophylactic antibiotics."
What types of conditions can be managed with Pre-operative Antibiotics?
"Pre-operative Antibiotics are frequently used to reduce the incidence of post-surgical infection and can help with bacterial endocarditis, anaerobic bacteria infections, and other microbial ailments."
To what extent can Pre-operative Antibiotics prove detrimental to individuals?
"The safety of Pre-operative Antibiotics was rated a 3, as it is has been approved by the relevant authorities and cleared through Phase 4 trials."
Share this study with friends
Copy Link
Messenger